status of compounded tirzepatide GLP-1 - Semaglutide & Tirzepatide dosage chart for weight

However, because the FDA has not officially stamped Mounjaro as a "PCOS treatment," the insurance computer system will immediately deny your healthcare provider's prescription

The dual agonism seems to lower hs-CRP levels about 30% more than GLP-1 mono-agonists do at the same amount of weight loss, which suggests that it has anti-inflammatory effects beyond just weight loss

Understanding this distinction helps manage expectations and alleviates unnecessary concerns for those considering or currently using the medication

Malhotra A, Ayappa I, Ayas N, et al

Understanding what to expect helps you stay committed to your weight loss journey

Before recommending semaglutide, tirzepatide, or another medically supervised weight-loss strategy, a physician may review weight history, prior weight-loss attempts, BMI, waist circumference, body composition goals, A1C, fasting glucose, insulin-resistance risk, cholesterol, triglycerides, blood pressure, liver enzymes, fatty liver risk, kidney function, current medications, diabetes medication use, history of pancreatitis, gallbladder disease, gastrointestinal symptoms, thyroid history, protein intake, exercise habits, sleep quality, hormonal symptoms, inflammation-related concerns, side-effect tolerance, and long-term maintenance planning